Development of a Molecular Blood-Based Immune Signature Classifier as Biomarker for Risks Assessment in Lung Cancer Screening
Authors:
- Orazio FortunatoOFOrazio Fortunato
- Veronica HuberVHVeronica Huber
- Miriam SegaleMSMiriam Segale
- Agata CovaACAgata Cova
- Viviana VallacchiVVViviana Vallacchi
- Paola SquarcinaPSPaola Squarcina
- Licia RivoltiniLRLicia Rivoltini
- Paola SuatoniPSPaola Suatoni
- Gabriella SozziGSGabriella Sozzi
- Ugo PastorinoUPUgo Pastorino
- Mattia BoeriMBMattia Boeri
Open Access
- 29 August 2022
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 31 (11) , 2020-2029
Abstract
Background: Low-dose CT (LDCT) screening trials have shown that lung cancer early detection saves lives. However, a better stratification of the screening population is still needed. In this respect, we generated and prospectively validated a plasma miRNA signature classifier (MSC) able to categorize screening participants according to lung cancer risk. Here, we aimed to deeply characterize the peripheral immune profile and develop a diagnostic immune signature classifier to further implement blood testing in lung cancer screening. Methods: Peripheral blood mononuclear cell (PBMC) samples collected from 20 patients with LDCT-detected lung cancer and 20 matched cancer-free screening volunteers were analyzed by flow cytometry using multiplex panels characterizing both lymphoid and myeloid immune subsets. Data were validated in PBMC from 40 patients with lung cancer and 40 matched controls and in a lung cancer specificity set including 27 subjects with suspicious lung nodules. A qPCR-based gene expression signature was generated resembling selected immune subsets. Results: Monocytic myeloid-derived suppressor cell (MDSC), polymorphonuclear MDSC, intermediate monocytes and CD8+PD-1+ T cells distinguished patients with lung cancer from controls with AUCs values of 0.94/0.72/0.88 in the training, validation, and lung cancer specificity set, respectively. AUCs raised up to 1.00/0.84/0.92 in subgroup analysis considering only MSC-negative subjects. A 14-immune genes expression signature distinguished patients from controls with AUC values of 0.76 in the validation set and 0.83 in MSC-negative subjects. Conclusions: An immune-based classifier can enhance the accuracy of blood testing, thus supporting the contribution of systemic immunity to lung carcinogenesis. Impact: Implementing LDCT screening trials with minimally invasive blood tests could help reduce unnecessary procedures and optimize cost-effectiveness.Keywords
All Related Versions
Funding Information
- Associazione Italiana per la Ricerca sul Cancro (IG 12162)
- Associazione Italiana per la Ricerca sul Cancro (23244)
- Associazione Italiana per la Ricerca sul Cancro (25078)
- Ministero della Salute (RF-2018-12367824)
- Ministero della Salute (GR-2016-02361849)
This publication has 41 references indexed in Scilit:
- Peripheral Immune Cell Gene Expression Predicts Survival of Patients with Non-Small Cell Lung CancerPLOS ONE, 2012
- Transcriptomic Analysis Comparing Tumor-Associated Neutrophils with Granulocytic Myeloid-Derived Suppressor Cells and Normal NeutrophilsPLOS ONE, 2012
- Resection of Non–Small Cell Lung Cancers Reverses Tumor-Induced Gene Expression Changes in the Peripheral Immune SystemClinical Cancer Research, 2011
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningNew England Journal of Medicine, 2011
- Transcriptional Profiling of Peripheral Blood Mononuclear Cells in Pancreatic Cancer Patients Identifies Novel Genes with Potential Diagnostic UtilityPLOS ONE, 2011
- MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancerProceedings of the National Academy of Sciences, 2011
- The number and microlocalization of tumor-associated immune cells are associated with patient's survival time in non-small cell lung cancerBMC Cancer, 2010
- Tumor-Infiltrating Foxp3+ Regulatory T Cells are Correlated with Cyclooxygenase-2 Expression and are Associated with Recurrence in Resected Non-small Cell Lung CancerJournal of Thoracic Oncology, 2010
- Gene Expression Profiles in Peripheral Blood Mononuclear Cells Can Distinguish Patients with Non–Small Cell Lung Cancer from Patients with Nonmalignant Lung DiseaseCancer Research, 2009
- Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinomaBritish Journal of Cancer, 2006